top of page

Stratence Partners Returns to the World EPA Congress 2026 – With Even Greater Impact

Stratence Partners at EPA Congress 2026 in Amsterdam

After the outstanding success of previous editions, Stratence Partners is proud to once again participate in the World Evidence, Pricing & Access Congress 2026, taking place in Amsterdam, March 3–4.


Recognized as Europe’s leading annual event for market access, pricing, and HEOR (Health Economics & Outcomes Research) professionals, the EPA Congress brings together more than 1,500 senior-level attendees and over 250 expert speakers from across the pharmaceutical, biotech, and payer sectors. It continues to grow as a global platform where strategy, science, and business intersect to shape the future of healthcare access.


Over the years, Stratence Partners has earned a strong reputation within the Congress for its thought-provoking sessions, strategic clarity, and the overwhelming interest generated among industry leaders. In 2025, our CEO Fernando Ventureira led two fully packed sessions that attracted dozens of follow-up conversations with global pharma executives.


This year, Fernando Ventureira will return to the stage, leading two high-impact sessions that reflect Stratence’s continued leadership in pricing strategy and digital transformation for healthcare.


Confirmed Contributions for 2026

  • March 3, 2026 – Pricing Track – 12:20 Fernando Ventureira will present on the future of strategic pricing in an increasingly regulated and value-driven market — offering practical guidance on how companies can strengthen their gross-to-net capabilities and maximize financial performance.

  • March 3, 2026 – AI & Digital Transformation Track – 13:00 In a second session, Fernando will explore the real-world application of AI and automation in commercial healthcare strategy — showing how pharma companies can translate technology into measurable results in pricing, market access, and patient impact.


More Than Just a Conference

In a context where access to treatment, budget pressure, and value demonstration define success in pharma, Stratence Partners continues to help healthcare companies make smarter decisions and deliver better results — through pricing excellence, market access innovation, and digital enablement.

We’re honored to be part of this outstanding community once again, and we look forward to sharing and learning alongside the best minds in the industry.


EARLY BIRD TICKETS UNTIL SEPTEMBER 26

Don’t miss the Early Bird rate to attend the EPA Congress 2026.Register now and secure your spot before September 26, 2025.


See you in Amsterdam: March 3-4, 2026.Together, let’s shape the future of healthcare strategy.

Comments


bottom of page